ストックスクリーナーアプリを入手
4.32
0.69%
-0.03
アフターアワーズ：
4.40
0.08
+1.85%
前日終値:
$4.35
開ける：
$4.36
24時間の取引高:
1.11M
Relative Volume:
0.96
時価総額：
$258.69M
収益：
-
当期純損益:
$-40.33M
株価収益率:
-2.4134
EPS:
-1.79
ネットキャッシュフロー:
$-39.53M
1週間 パフォーマンス:
+24.14%
1か月 パフォーマンス:
+66.80%
6か月 パフォーマンス:
+36.71%
1年 パフォーマンス:
-7.10%
1日の値動き範囲:
$4.13
$4.45
1週間の範囲:
$3.40
$4.52
52週間の値動き範囲:
$2.315
$5.54
Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile
名前
Eledon Pharmaceuticals Inc
セクター
電話
949-238-8090
住所
19800 MACARTHUR BLVD., IRVINE
ELDN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ELDN
Eledon Pharmaceuticals Inc
|
4.32 | 260.49M | 0 | -40.33M | -39.53M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-18 | 再開されました | H.C. Wainwright | Buy |
| 2025-01-28 | 開始されました | Guggenheim | Buy |
| 2022-05-13 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-03-23 | 開始されました | Cantor Fitzgerald | Overweight |
Eledon Pharmaceuticals Inc (ELDN) 最新ニュース
Market reaction to Eledon Pharmaceuticals Inc.’s recent newsWeekly Profit Report & Fast Exit and Entry Strategy Plans - newser.com
Can Eledon Pharmaceuticals Inc. recover in the next quarterEarnings Growth Summary & Entry Point Strategy Guides - newser.com
Can Eledon Pharmaceuticals Inc. (2TK) stock double in coming yearsGap Down & Long-Term Investment Growth Plans - newser.com
Is Eledon Pharmaceuticals Inc. (2TK) stock supported by strong fundamentalsBull Run & Target Return Focused Stock Picks - newser.com
What dividend safety rating applies to Eledon Pharmaceuticals Inc. (2TK) stockMarket Volume Summary & Community Consensus Stock Picks - newser.com
Eledon Pharmaceuticals Inc. stock momentum explainedInflation Watch & Target Return Focused Picks - newser.com
Will breakout in Eledon Pharmaceuticals Inc. lead to full recoveryJuly 2025 Rallies & Real-Time Volume Spike Alerts - newser.com
Is Eledon Pharmaceuticals Inc. stock a buy in volatile marketsJuly 2025 Short Interest & High Conviction Trade Alerts - newser.com
Is Eledon Pharmaceuticals Inc. (2TK) stock attractive post correctionJuly 2025 Sentiment & Daily Volume Surge Trade Alerts - newser.com
Real time scanner hits for Eledon Pharmaceuticals Inc. explainedPortfolio Risk Summary & Growth Focused Stock Reports - newser.com
Short Interest in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Declines By 47.4% - MarketBeat
Will Eledon Pharmaceuticals Inc. stock gain from lower inflation2025 Earnings Impact & Community Verified Swing Trade Signals - newser.com
How Eledon Pharmaceuticals Inc. (2TK) stock valuation compares with sectorJuly 2025 Price Swings & Verified Trade Idea Suggestions - newser.com
Published on: 2025-11-01 03:53:10 - newser.com
Using AI based signals to follow Eledon Pharmaceuticals Inc.Earnings Growth Summary & Community Verified Watchlist Alerts - newser.com
Will Eledon Pharmaceuticals Inc. (2TK) stock beat revenue estimatesPortfolio Risk Summary & Long-Term Safe Investment Plans - newser.com
Published on: 2025-10-31 05:05:04 - newser.com
Is this a good reentry point in Eledon Pharmaceuticals Inc.2025 Dividend Review & Free Accurate Trade Setup Notifications - newser.com
Eledon Pharmaceuticals’ AT 1501: A Promising Kidney Transplant Study Update - TipRanks
Why analysts remain bullish on Eledon Pharmaceuticals Inc. stock2025 Earnings Surprises & Stepwise Trade Signal Guides - newser.com
Published on: 2025-10-31 03:44:59 - newser.com
Published on: 2025-10-31 03:36:14 - newser.com
Eledon Pharmaceuticals Inc. stock daily chart insights2025 Valuation Update & Reliable Momentum Entry Alerts - newser.com
Published on: 2025-10-31 00:00:36 - newser.com
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Eledon Pharmaceuticals Inc (ELDN) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):